Glitamen Tablet 15/850 mg

Adult dosage

The dosage of this drug should be individualized based on efficacy and tolerability, adhering to the maximum doses of the components, pioglitazone 30 mg and metformin 2500 mg. The initial dose is based on the patient's current treatment regimen. 1. In patients who cannot adequately control blood sugar with monotherapy using metformin or pioglitazone, start with this drug at 1 tablet per day based on the currently administered dose and evaluate treatment response.

This drug consists of two components that help lower blood sugar. The first component may cause a rare side effect called lactic acidosis, in which excess lactic acid builds up in the body; this condition can be very serious and life-threatening if untreated. Therefore, patients with reduced kidney function or problems with the heart or lungs, and those with sepsis or dehydration should not use this drug or should do so with extreme caution. Additionally, patients with impaired liver function should not take this drug. Excessive alcohol consumption may increase the risk of side effects, so alcohol should be avoided during treatment. The second component can worsen heart failure, so patients with poor heart function should not use this drug. If symptoms of heart failure occur, consult a doctor immediately, and the dosage may need to be adjusted or stopped if necessary. This component may also cause fluid retention, leading to swelling or weight gain, so caution is advised. Patients with a history of bladder cancer or those currently with active bladder cancer should not be administered this drug. If any abnormal symptoms such as hematuria or urinary disorders occur during treatment, notify a doctor immediately. Pregnant or breastfeeding women should not take this drug, and safety in pediatric patients has not been established. Elderly patients may have reduced kidney function, so the dosage of this drug should be determined carefully, and kidney function should be monitored regularly. During treatment with this drug, regular monitoring of blood glucose, blood tests, liver function tests, and kidney function tests should be performed, and it is recommended to also check vitamin B12 levels. If symptoms of hypoglycemia or early symptoms of lactic acidosis (such as difficulty breathing, muscle pain, fatigue, altered consciousness, etc.) occur, stop taking this drug immediately and inform healthcare personnel. Additionally, this drug may interact with other medications, so inform healthcare personnel of any other medications being taken, and treatment with this drug may need to be temporarily discontinued before and after surgery. Lastly, it is important to combine dietary and exercise therapies for normal blood sugar control, and safe intake should be ensured through regular check-ups and consultations with healthcare personnel.

Serious side effects

Severe lactic acidosis, hypoglycemia, acute kidney function deterioration, cardiopulmonary diseases, sepsis, liver abnormalities, liver failure, congestive heart failure, rapid weight gain, worsening edema, serious skin reactions, severe allergic reactions, severe neurological symptoms, severe edema accompanied by high blood pressure, severe respiratory problems, urinary disorders, urgency in urination, bladder cancer, worsening of heart failure, jaundice, serious liver damage, acute renal failure, symptoms associated with lactic acidosis (weakness)

Mild side effects

Upper respiratory tract infection, diarrhea, nausea, headache, urinary tract infection, sinusitis, dizziness, lower limb edema, weight gain, muscle pain, dental disorders, worsening of diabetes, pharyngitis, anemia, indigestion, insomnia, dry mouth, constipation, abdominal bloating, gastroesophageal reflux disease, intestinal gas retention, increased serum creatinine, increased urea in blood, diabetic macular edema accompanied by decreased vision, fractures

This drug should be stored in a tightly closed container to protect it from air and moisture. It is also advisable to keep the drug at room temperature between 1 and 30 degrees Celsius, avoiding too hot or too cold places.

Appearance

White to grayish-white rectangular film-coated tablet

Package unit

30 tablets (10 tablets/PTP*3)